{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "AGCO",
  "name": "AGCO Corporation",
  "url": "https://frontierpicks.com/dossiers/AGCO/",
  "json_url": "https://frontierpicks.com/dossiers/AGCO.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a1",
    "n": 1
  },
  "current_thesis": "Trough-earnings ag-equipment re-rating on a 2027 North American row-crop recovery: Baird's 2026-08-31 upgrade (target $120→$150, ~$10 of 2027 EPS power) took the shares from about $118 to a $133.40 close on 2026-09-04, +6.02% on 2M shares against a 1.44M average. The 2026 guide still descends ($10.1–10.2B sales, $5.50–5.75 EPS), so the leg is priced entirely off 2027 with no company-dated print before the Q3 report in early November.",
  "invalidation_trigger": "A weekly close below $118 round-trips the entire post-2026-08-31 upgrade leg; secondarily, the 09-09 and 09-10 conference appearances and the September WASDE passing with no upward revision to 2027 North American row-crop demand while price sits above the $122.47 mean sell-side target of 2026-08-31.",
  "catalyst_date": "2026-09-09",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "cyclical-industrials",
    "semi-foundry-equipment",
    "precision-biotech-therapeutics"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Q3 results have landed in early November in prior years; no company-reported print falls inside 30 days of 2026-09-06.",
    "PTx Trimble, the precision-ag joint venture formed in 2024, is 85% AGCO-owned and consolidates into AGCO's precision-ag revenue line.",
    "2026 guidance embeds an assumed net tariff cost of about $95M; a policy change re-cuts the EPS bridge in either direction."
  ],
  "body_markdown": "## Current Thesis\n\nThe leg being bought is a trough-earnings cyclical re-rating: 2026 is guided as the bottom of the North American row-crop equipment cycle, and the buyer is paying today for the operating leverage of a 2027 volume recovery off that low base. AGCO guided full-year 2026 net sales to $10.1–10.2B, EPS to $5.50–5.75 and adjusted operating margin to about 7.5% at the 2026-07-30 Q2 release. Baird's Mircea Dobre upgraded the shares to Outperform on 2026-08-31, lifting the target to $150 from $120 on the argument that any North American volume recovery in 2027 drops straight to the bottom line and that 2027 earnings power sits near $10 per share. The shares closed $133.40 on 2026-09-04, up 6.02% on the session, on 2M shares against a 1.44M average — the re-rating is happening on sell-side and product-cycle news, not on an order book that has turned. Nothing company-dated resolves this before the Q3 print, which has landed in early November in prior years.\n\n## Bull Case\n\n- Baird upgrade 2026-08-31: Outperform from Neutral, target $150 from $120, framed on North American row-crop demand and Fendt share gains, with 2027 earnings power near $10/share. The same note carried Deere, and both names rallied about 4% that day.\n- Guided 2026 adjusted operating margin of about 7.5% (2026-07-30) is a cycle-trough margin for a business that has run materially higher in up-cycles; the bull arithmetic is margin recovery on recovering volume rather than new share.\n- Product cadence into the segment where the share-gain claim lives: Fendt 1100 Vario MT Gen2 track tractor, Momentum 80-foot planter and 300 Vario Gen5 launched at the Farm Progress Show on 2026-09-01, followed by the Massey Ferguson N-Series split/narrow-row planter on 2026-09-02.\n- Aftermarket build-out: an expanded 115,000 sq ft parts distribution centre opened in Visalia, California on 2026-08-31 — parts revenue is the least cyclical line in the mix.\n- Precision ag reorganisation announced 2026-08-03 (\"AGCO Aligns Leadership to Advance PTx Growth Strategy\"), the internal marker for the higher-margin technology attach story.\n- Cluster support: the Cyclical industrials group (CNH, TITN, MTW, BWMN, RCMT) flipped back to accelerating on 2026-09-06 after a maturing read on 2026-08-26.\n\n## Bear Case\n\n- Q2 2026 (2026-07-30) missed on both lines: adjusted EPS $1.43 against $1.45 consensus, net sales $2.61B against roughly $2.75B expected and down about 1% year-over-year, with Europe and Latin America weak as farmers cited elevated input costs and financing rates. The full-year outlook came down with it.\n- Q3 2026 guidance of $2.3–2.4B in net sales and $0.85–0.90 EPS is a sequential step down from Q2's $2.61B. The recovery is a 2027 claim; the guided 2026 numbers still descend.\n- 2026 guidance embeds a net tariff impact of about $95M, gross costs of roughly $115M partly offset by IEEPA refunds already recognised — a live policy variable that has already moved once this year.\n- Valuation is not doing the work: stockanalysis.com showed a 20.57 forward P/E and a $9.34B market cap on 2026-09-04, i.e. a mid-cycle multiple applied to trough earnings.\n- Price sits above the street: the mean sell-side target was $122.47 on 2026-08-31, below the 2026-09-04 close of $133.40. The re-rating is running ahead of consensus targets rather than being pulled by them.\n- Rate backdrop: long-end Treasury yields snapped back toward 20-month highs on 2026-08-20, and financing cost is the same variable management named as the demand constraint on the Q2 call.\n\n## Setup & Price Structure\n\nThe 52-week range is $98.22–$143.78 with a $133.40 close on 2026-09-04 (stockanalysis.com); StockStory put the February 2026 high at $140.49 when the shares changed hands near $118.31 on 2026-08-31, so the overhead supply band spans roughly the high $130s to mid $140s depending on whether the high is read intraday or on the close. Four sessions carried the name from that $118 area to $133.40, the last of them a $126.20–$135.17 wide-range day closing at the top on volume 39% above the 1.44M average. That day's $126.20 low is the first reference shelf beneath the market; the $118 area is where the entire post-upgrade leg began.\n\nOn crowding: the narrative is accelerating — the upgrade landed 2026-08-31, the Farm Progress launches on 09-01 and 09-02, the expansion-volume session on 09-04, and the theme cluster turned back to accelerating on 09-06. The observables that cut the other way are in the same window: price above the $122.47 mean target of 2026-08-31, two sell-side conference appearances booked for 09-09 and 09-10 into an already vertical move, and a run into the upper third of the 52-week range with no company-reported datapoint scheduled before the Q3 print. No Form 4 activity appears in the filings feed for the trailing 30 days.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-09-09** — Presentation at Citi's 2026 Global TMT Conference (announced 2026-08-27).\n- **2026-09-10** — Presentation at the 2026 Jefferies Global Industrials Conference (announced 2026-08-28). First management commentary since the 07-30 guidance cut and the 08-31 upgrade.\n- **~2026-09-10 (est.)** — Monthly AEM US ag tractor and combine retail unit report for August; the cleanest public read on whether North American large-tractor retail demand is bottoming.\n- **~2026-09-11 (est.)** — USDA September WASDE; grain price and farm-income input into 2027 order intake.\n- **2026-09-15** — Quarterly dividend of $0.30/share payable.\n- **~2026-11-04 (est.)** — Q3 2026 results against the $2.3–2.4B / $0.85–0.90 EPS guide, and the first hard test of the 2027 recovery frame.\n\n## What Would Change Our Mind\n\nThe leg was built in four sessions on an analyst upgrade and a trade-show product cycle, so the thing that breaks it is the same tape giving that back before any order data arrives. A weekly close below $118 round-trips the entire post-2026-08-31 move and puts the shares back where they sat before the recovery frame was repriced. A lesser but still material break is a daily close below $126.20, which loses the low of the 2026-09-04 expansion session. On the fundamental side, the 09-09 and 09-10 conference appearances plus the September WASDE passing without a positive revision to North American row-crop demand — while price holds above the $122.47 mean target of 2026-08-31 — would mark the story as fully discounted on sell-side voice alone. A Q3 print in early November inside or below the $2.3–2.4B guide, with Europe down year-over-year again, would push the recovery claim into 2028 and remove the reason the multiple was raised.\n\n## Correlation Notes\n\nAGCO trades as the higher-beta expression of the same North American row-crop call that drives Deere: Baird upgraded both on 2026-08-31 and both rallied about 4%. Within the Cyclical industrials cluster, CNH is the direct comparable and TITN the dealer-level read on retail demand and used inventory, so a TITN guide-down would contradict the AGCO recovery frame more directly than any macro print. MTW, BWMN and RCMT sit in the same cluster but on construction and staffing end-markets, so cluster acceleration is only partial evidence for this name. Two exogenous drivers sit outside company control: grain prices via WASDE and farm income, and the long end of the Treasury curve, which was near 20-month highs on 2026-08-20 and feeds directly into dealer floorplan and retail financing costs that management named as a demand constraint on 2026-07-30.",
  "first_seen": "2026-09-06",
  "last_analyzed": "2026-09-06T08:22:13+00:00",
  "last_synthesized": "2026-09-06",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}